Patent · US Active

Method of treating multiple sclerosis employing a LSD1-inhibitor

US10780081B2 · kind B2 · utility

1Cited by

20References

19Claims

0Family size

Assignee

Oryzon Genomics S.A. · ES

Inventors

Tamara Maes · Castelldefels, ES
Cristina MASCARO CRUSAT · Cornellà de Llobregat, ES
David ROTLLANT POZO · Cornellà de Llobregat, ES

Key dates

Filing date	Jun 9, 2017
Grant date	Sep 22, 2020
Priority date	—
Expiry date	Jun 9, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods for treating multiple sclerosis using (−) 5-((((trans)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine, or a pharmaceutically acceptable salt or solvate thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.